← Back to headlines

Gleevec's 25-year legacy in transforming cancer treatment
The approval of the drug Gleevec 25 years ago for a form of leukemia is highlighted as a pivotal moment that ushered in a new era of cancer care.
10 May, 11:00 — 10 May, 11:00
Sources
Showing 1 of 1 sources


